Peter Rhode

Insider Reports History

Location
Miramar, FL
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Peter Rhode
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Rhode:

Company Role Class Num Shares Value Price $ Report Date Ownership
HCW Biologics Inc. Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. Common Stock 77,500 $161,061 $2.08 11 Dec 2023 Direct
HCW Biologics Inc. Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. Stock Option Grant (Right to Buy) 36,427 17 Nov 2023 Direct
HCW Biologics Inc. Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. Stock Option (Right to Buy) 22,427 11 Dec 2023 Direct

Insider Reports Filed by Peter Rhode

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HCWB HCW Biologics Inc. 11 Dec 2023 2 +$1,960 4 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 11 Dec 2023, 16:56
HCWB HCW Biologics Inc. 17 Nov 2023 2 +$2,100 4 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 20 Nov 2023, 16:55
HCWB HCW Biologics Inc. 14 Jan 2022 4 +$360 4 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 19 Jan 2022, 16:42
HCWB HCW Biologics Inc. 08 Sep 2021 1 $0 4 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 10 Sep 2021, 17:48
HCWB HCW Biologics Inc. 22 Jul 2021 1 +$100,000 4 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 23 Jul 2021, 19:30
HCWB HCW Biologics Inc. 19 Jul 2021 0 $0 3 Officer 19 Jul 2021, 17:00